Calidi Biotherapeutics (CLDI) Amortizatization of Intangibles (2022 - 2025)
Calidi Biotherapeutics' quarterly Amortizatization of Intangibles came in at $303000.0 in Q1 2025, up 11.4% year-on-year from $272000.0 in Q1 2024, and up 7475.0% quarter-over-quarter from $4000.0 in Q4 2024.
Calidi Biotherapeutics has reported Amortizatization of Intangibles for 4 years, with the latest figure at $303000.0 in Q1 2025.
- For the quarter ending Q1 2025, Amortizatization of Intangibles rose 11.4% year-over-year to $303000.0; the trailing twelve-month figure through Mar 2025 stood at $76000.0 (down 90.63% YoY), and the FY2024 full-year result was $45000.0, down 94.79% from the prior year.
- Amortizatization of Intangibles for Q1 2025 stood at $303000.0, up from $4000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $303000.0 in Q1 2025, with the low at -$240000.0 in Q2 2024.
- Average Amortizatization of Intangibles over 4 years is $120752.3, with a median of $160000.0 recorded in 2022.
- Year-over-year, Amortizatization of Intangibles jumped 122.69% in 2023 and sank 1552.52% in 2024.
- Tracing CLDI's Amortizatization of Intangibles over 4 years: stood at $119000.0 in 2022, then jumped by 122.69% to $265000.0 in 2023, then sank by 98.49% to $4000.0 in 2024, then jumped by 7475.0% to $303000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $303000.0 (Q1 2025), $4000.0 (Q4 2024), and $9000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Calidi Biotherapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 303,000.00 |
| Mar 31, 2025 | 303,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | -240,000.00 |
| Jun 30, 2024 | -240,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Dec 31, 2023 | 265,000.00 |
| Dec 31, 2023 | 265,000.00 |
| Sep 30, 2023 | 258,000.00 |
| Sep 30, 2023 | 258,000.00 |
| Jun 30, 2023 | 16,523.00 |
| Jun 30, 2023 | 16,523.00 |
| Mar 31, 2023 | 201,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Dec 31, 2022 | 119,000.00 |
| Dec 31, 2022 | 119,000.00 |